United Kingdom· GB-APID-14236111000001106
Doribax 500mg powder for solution for infusion vials
A doripenem product containing doripenem, registered in United Kingdom by Janssen-Cilag Ltd. The same ATC class is registered in 3 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Doripenem is registered in 3 of 19 countries.
Countries holding a registration under ATC J01DH04 (doripenem), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Doripenem · ATC J01DH04
3 / 19 countries
- Finlandprice
- Japan
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Doripenem
- Manufacturer
- Janssen-Cilag Ltd
- Country
- United Kingdom (GB)
- ATC code
- J01DH04
- ATC class
- Doripenem
- Defined daily dose
- 1.5 g, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5012674901762
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
9 interactions on record for doripenem.
Graded by severity as the source publishes them — 8 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Doripenem · interactions on record
9 records
- 8 moderate
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- Levonorgestrel and ethinylestradiolG03AA07moderate
- Desogestrel and ethinylestradiolG03AA09moderate
- Drospirenone and ethinylestradiolG03AA12moderate
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Doripenem in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/55971f49-62a4-43f0-88d6-5a64275e6d8e GET /v1/drugs/55971f49-62a4-43f0-88d6-5a64275e6d8e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "14236111000001106",
"desc": "Doribax 500mg powder for solution for infusion vials (Janssen-Cilag Ltd)",
"form": "Powder for solution for infusion",
"vpid": "41948211000001107",
"source": "dmd",
"vtm_id": "775689001",
"strength": "500 mg",
"substance": "Doripenem",
"ingredient": "Doripenem monohydrate",
"supplier_code": "2422501000001106"
}See everything about doripenem.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.